170 related articles for article (PubMed ID: 30542712)
1. A two‑circRNA signature predicts tumour recurrence in clinical non‑functioning pituitary adenoma.
Guo J; Wang Z; Miao Y; Shen Y; Li M; Gong L; Wang H; He Y; Gao H; Liu Q; Li C; Zhang Y
Oncol Rep; 2019 Jan; 41(1):113-124. PubMed ID: 30542712
[TBL] [Abstract][Full Text] [Related]
2. Identification of a multidimensional transcriptome signature predicting tumor regrowth of clinically non‑functioning pituitary adenoma.
Cheng S; Guo J; Zhang Y; Li Z; Li C
Int J Oncol; 2020 Sep; 57(3):804-812. PubMed ID: 32582995
[TBL] [Abstract][Full Text] [Related]
3. A Novel Three-LncRNA Signature Predicting Tumor Recurrence in Nonfunctioning Pituitary Adenomas.
Cheng S; Guo J; Wang D; Fang Q; Liu Y; Xie W; Zhang Y; Li C
Front Genet; 2021; 12():754503. PubMed ID: 34745223
[TBL] [Abstract][Full Text] [Related]
4. Predicting the regrowth of clinically non-functioning pituitary adenoma with a statistical model.
Cheng S; Wu J; Li C; Li Y; Liu C; Li G; Li W; Hu S; Ying X; Zhang Y
J Transl Med; 2019 May; 17(1):164. PubMed ID: 31109334
[TBL] [Abstract][Full Text] [Related]
5. Presentation and surgical results of incidentally discovered nonfunctioning pituitary adenomas: evidence for a better outcome independently of other patients' characteristics.
Losa M; Donofrio CA; Barzaghi R; Mortini P
Eur J Endocrinol; 2013 Dec; 169(6):735-42. PubMed ID: 23999643
[TBL] [Abstract][Full Text] [Related]
6. Estrogen Receptor α, a Sex-Dependent Predictor of Aggressiveness in Nonfunctioning Pituitary Adenomas: SSTR and Sex Hormone Receptor Distribution in NFPA.
Øystese KA; Casar-Borota O; Normann KR; Zucknick M; Berg JP; Bollerslev J
J Clin Endocrinol Metab; 2017 Sep; 102(9):3581-3590. PubMed ID: 28911153
[TBL] [Abstract][Full Text] [Related]
7. Nonfunctioning Pituitary Adenoma Recurrence and Its Relationship with Sex, Size, and Hormonal Immunohistochemical Profile.
Batista RL; Trarbach EB; Marques MD; Cescato VA; da Silva GO; Herkenhoff CGB; Cunha-Neto MB; Musolino NR
World Neurosurg; 2018 Dec; 120():e241-e246. PubMed ID: 30138730
[TBL] [Abstract][Full Text] [Related]
8. Frequency, pattern, and outcome of recurrences after gamma knife radiosurgery for pituitary adenomas.
Losa M; Spatola G; Albano L; Gandolfi A; Del Vecchio A; Bolognesi A; Mortini P
Endocrine; 2017 Jun; 56(3):595-602. PubMed ID: 27688011
[TBL] [Abstract][Full Text] [Related]
9. Integrated analysis of DNA methylation and mRNA expression profiles to identify key genes involved in the regrowth of clinically non-functioning pituitary adenoma.
Cheng S; Li C; Xie W; Miao Y; Guo J; Wang J; Zhang Y
Aging (Albany NY); 2020 Feb; 12(3):2408-2427. PubMed ID: 32015217
[TBL] [Abstract][Full Text] [Related]
10. Differential circular RNA expression profiles of invasive and non-invasive non-functioning pituitary adenomas: A microarray analysis.
Hu Y; Zhang N; Zhang S; Zhou P; Lv L; Richard SA; Ma W; Chen C; Wang X; Huang S; Jiang S
Medicine (Baltimore); 2019 Jun; 98(26):e16148. PubMed ID: 31261542
[TBL] [Abstract][Full Text] [Related]
11. Predicting recurrence of nonfunctioning pituitary adenomas.
Noh TW; Jeong HJ; Lee MK; Kim TS; Kim SH; Lee EJ
J Clin Endocrinol Metab; 2009 Nov; 94(11):4406-13. PubMed ID: 19820025
[TBL] [Abstract][Full Text] [Related]
12. Long-term recurrence and mortality after surgery and adjuvant radiotherapy for nonfunctional pituitary adenomas.
Chang EF; Zada G; Kim S; Lamborn KR; Quinones-Hinojosa A; Tyrrell JB; Wilson CB; Kunwar S
J Neurosurg; 2008 Apr; 108(4):736-45. PubMed ID: 18377253
[TBL] [Abstract][Full Text] [Related]
13. Comparing progression of non-functioning pituitary adenomas in hypopituitarism patients with and without long-term GH replacement therapy.
Olsson DS; Buchfelder M; Schlaffer S; Bengtsson BA; Jakobsson KE; Johannsson G; Nilsson AG
Eur J Endocrinol; 2009 Nov; 161(5):663-9. PubMed ID: 19734242
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Ki67, HMGA1, MDM2, and RB expression in nonfunctioning pituitary adenomas.
Yao X; Gao H; Li C; Wu L; Bai J; Wang J; Li Y; Zhang Y
J Neurooncol; 2017 Apr; 132(2):199-206. PubMed ID: 28255749
[TBL] [Abstract][Full Text] [Related]
15. Relevance of Ki-67 and prognostic factors for recurrence/progression of gonadotropic adenomas after first surgery.
Dubois S; Guyétant S; Menei P; Rodien P; Illouz F; Vielle B; Rohmer V
Eur J Endocrinol; 2007 Aug; 157(2):141-7. PubMed ID: 17656591
[TBL] [Abstract][Full Text] [Related]
16. Microarray Expression Profile of Circular RNAs in Plasma from Primary Biliary Cholangitis Patients.
Zheng J; Li Z; Wang T; Zhao Y; Wang Y
Cell Physiol Biochem; 2017; 44(4):1271-1281. PubMed ID: 29183005
[TBL] [Abstract][Full Text] [Related]
17. Plasma circular RNA panel acts as a novel diagnostic biomarker for colorectal cancer.
Lin J; Cai D; Li W; Yu T; Mao H; Jiang S; Xiao B
Clin Biochem; 2019 Dec; 74():60-68. PubMed ID: 31669510
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA In Invasive and Recurrent Clinical Nonfunctioning Pituitary Adenomas: Expression Profiles and Bioinformatic Analysis.
Wang J; Wang D; Wan D; Ma Q; Liu Q; Li J; Li Z; Gao Y; Jiang G; Ma L; Liu J; Li C
World Neurosurg; 2018 Sep; 117():e371-e386. PubMed ID: 29909209
[TBL] [Abstract][Full Text] [Related]
19. Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: markers of tumour quiescence and regrowth.
Greenman Y; Ouaknine G; Veshchev I; Reider-Groswasser II; Segev Y; Stern N
Clin Endocrinol (Oxf); 2003 Jun; 58(6):763-9. PubMed ID: 12780754
[TBL] [Abstract][Full Text] [Related]
20. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
